Sorta important being that the AML relapse rate is so high and so lethal. Hope Imetelstat can help these patients. I wonder if Imetelstat works selectively against particular sub-types, or if it works against all of the AML groups ? . Best of luck all.
" Patients with acute myeloid leukemia (AML) could be separated genomically into at least 11 major groups, each with different constellations of genetic changes and distinctive clinical features, say researchers. This genetic complexity helps explain why AML shows such variability in survival rates among patients. Full knowledge of the genetic make-up of a patient's leukemia substantially improved the ability to predict whether that patient would be cured with current treatments."